PLEASANTON, Calif.,
Feb. 7, 2022 /PRNewswire/ -- Movano
Inc. (Nasdaq: MOVE), a health technology company designing devices
that inspire and empower you to live a healthier, happier life,
announced that it will be participating in the virtual BTIG
MedTech, Digital Health, Life Science & Diagnostic Tools
Conference on Tuesday, February 15 –
Thursday, February 17, 2022. Movano's
CEO, John Mastrototaro, who has over
30 years of experience in the medical device industry and was
instrumental in initiating and leading a series of firsts in the
diabetes space, will present on behalf of the Company and provide
an overview of its debut device, the Movano Ring, which was
recently showcased at CES 2022.
BTIG hosted events are intended for prospective and existing
BTIG clients only. To listen to the live event, please contact your
BTIG representative with interest.
About Movano
Founded in 2018, Movano Inc. is a
health-focused technology company creating simple, smart and
personalized devices designed to inspire and empower individuals on
their health journey live a happier, healthier life. Movano's
technology is being developed to provide vital health information,
including glucose and blood pressure data, in a variety of form
factors to meet individual style needs and give users actionable
feedback in order to improve the quality of their life. For more
information, visit https://movano.com/.
Forward Looking Statements
This press
release contains forward-looking statements concerning our
expectations, anticipations, intentions, beliefs or strategies
regarding the future. These forward-looking statements are based on
assumptions that we have made as of the date hereof and are subject
to known and unknown risks and uncertainties that could cause
actual results, conditions and events to differ materially from
those anticipated. Therefore, you should not place undue reliance
on forward-looking statements. Examples of forward-looking
statements include, among others, statements we make regarding
expected future operating results; product development, clinical
trial and regulatory initiatives; our strategies, positioning and
expectations for future events or performance. Important factors
that could cause actual results to differ materially from those in
the forward-looking statements are set forth in our registration
statement on Form S-1, as amended, and any subsequent Quarterly
Reports on Form 10-Q, and in our other reports filed with the
Securities and Exchange Commission, including under the caption
"Risk Factors." Any forward-looking statement in this release
speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-to-participate-in-btig-medtech-digital-health-life-science--diagnostic-tools-conference-301476026.html
SOURCE Movano